---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-005673"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2024-02-20T23:59:59+00:00"
generated_at: "2026-06-05T23:41:15.989772+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Medifast Q4 revenue falls 43% to $191M; guides Q1 2024 revenue $155-175M

## Summary
- Q4 net income $6.0M ($0.55 diluted EPS); adjusted net income $11.9M ($1.09 adjusted EPS).
- Active OPTA VIA Coaches down 32.5% YoY to 41,100; revenue per coach fell 16.1% to $4,648.
- Full-year 2023 revenue $1.1B, down 32.9% YoY; net income $99.4M ($9.10 diluted EPS).
- Q1 2024 revenue guidance $155-175M; diluted EPS $0.25-0.95, excluding LifeMD collaboration costs.
- Cash and investments $150M, no interest-bearing debt; company pivoting to medically-supported weight loss with LifeMD.

## SEC filing metadata
- accession: 0001628280-24-005673
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2024-02-20T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828024005673/0001628280-24-005673-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828024005673/med-20240220.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-005673
- JSON: https://secwatch.observer/filing/0001628280-24-005673.json
- Plain text: https://secwatch.observer/filing/0001628280-24-005673.txt

## Key facts
- Earnings Releases
  MEDIFAST INC reported Full Year 2023 results: revenue $1.1 billion, net income $99.4 million, EPS $9.10.
  - Period: Full Year 2023
  - Revenue: $1.1 billion
  - Net income: $99.4 million
  - EPS: $9.10
  - Result: reported results
  source text: Full Year 2023 • Revenue of $1.1 billion • Net income of $99.4 million (non-GAAP adjusted net income of $105.2 million) • EPS of $9.10 (non-GAAP adjusted EPS of $9.64)
  evidence_url: https://www.sec.gov/Archives/edgar/data/910329/000162828024005673/0001628280-24-005673-index.htm
- Earnings Releases
  MEDIFAST INC reported fourth quarter and full year ended December 31, 2023 results: revenue $191.0 million, net income $6.0 million, EPS $0.55 per diluted share.
  - Period: fourth quarter and full year ended December 31, 2023
  - Revenue: $191.0 million
  - Net income: $6.0 million
  - EPS: $0.55 per diluted share
  - Result: reported results
  source text: Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTA VIA®, today reported results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 • Revenue of $191.0 million, with revenue per active earning Coach of $4,648 • Independent active earning OPTA VIA Coaches of 41,100 • Net income of $6.0 million (non-GAAP adjusted net income of $11.9 million) • Earnings per diluted share ("EPS") of $0.55 (non-GAAP adjusted EPS of $1.09) Full Year 2023 • Revenue of $1.1 billion • Net income of $99.4 million (non-GAAP adjusted net income of $105.2 million) • EPS of $9.10 (non-GAAP adjusted EPS of $9.64) • Cash, Cash Equivalents, and Investments of $150.0 million and no interest-bearing debt
  evidence_url: https://www.sec.gov/Archives/edgar/data/910329/000162828024005673/0001628280-24-005673-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.